Published in Mol Pharmacol on December 01, 2002
Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications. Neuropharmacology (2008) 1.16
Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model. Drug Test Anal (2012) 1.13
Physical interaction of calmodulin with the 5-hydroxytryptamine2C receptor C-terminus is essential for G protein-independent, arrestin-dependent receptor signaling. Mol Biol Cell (2008) 1.08
Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder. Pharmacol Rev (2015) 1.06
Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction. Neuropharmacology (2013) 1.05
Kappa opioids promote the proliferation of astrocytes via Gbetagamma and beta-arrestin 2-dependent MAPK-mediated pathways. J Neurochem (2008) 1.05
Role of G(q) protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane. Neuropharmacology (2007) 0.90
Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice. BMC Pharmacol (2011) 0.87
Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex. Neuroscience (2015) 0.84
Quantitative changes in intracellular calcium and extracellular-regulated kinase activation measured in parallel in CHO cells stably expressing serotonin (5-HT) 5-HT2A or 5-HT2C receptors. BMC Neurosci (2012) 0.83
Phospholipase D signaling in serotonin-induced mitogenesis of pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2008) 0.81
Serotonin 5-HT(2C) receptor homodimerization is not regulated by agonist or inverse agonist treatment. Eur J Pharmacol (2007) 0.80
How much do we know about the coupling of G-proteins to serotonin receptors? Mol Brain (2014) 0.78
Nucleus accumbens shell excitability is decreased by methamphetamine self-administration and increased by 5-HT2C receptor inverse agonism and agonism. Neuropharmacology (2014) 0.78
Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology. Exp Brain Res (2013) 0.77
RNA editing of the serotonin 2C receptor and expression of Galpha(q) protein: genetic mouse models do not support a role for regulation or compensation. J Neurochem (2009) 0.77
Amygdala-Hippocampal Phospholipase D (PLD) Signaling As Novel Mechanism of Cocaine-Environment Maladaptive Conditioned Responses. Int J Neuropsychopharmacol (2016) 0.75
Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature (1997) 7.92
RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem (1999) 2.10
Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J Biol Chem (1997) 2.01
RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology (2001) 1.62
RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. Br J Pharmacol (2001) 1.27
Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing. Mol Pharmacol (1996) 1.27
Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor. J Biol Chem (1998) 1.25
Actions of drugs that deplete serotonin. Fed Proc (1977) 1.24
Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience (2003) 1.21
A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc Natl Acad Sci U S A (1986) 1.20
Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands. J Biol Chem (1994) 1.16
Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors. Pharmacol Biochem Behav (1998) 1.16
Transferrin gene expression and synthesis by cultured choroid plexus epithelial cells. Regulation by serotonin and cyclic adenosine 3',5'-monophosphate. J Biol Chem (1989) 1.15
Comparison of the pharmacological characteristics of 5 HT1 and 5 HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release. Naunyn Schmiedebergs Arch Pharmacol (1982) 1.14
Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. Genes Brain Behav (2007) 1.12
Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A. Neuroscience (2008) 1.09
Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo. Neuroscience (1999) 1.08
RNA editing of the human serotonin 5-HT2C receptor alters receptor-mediated activation of G13 protein. J Biol Chem (2001) 1.04
Identification and characterization of RNA editing events within the 5-HT2C receptor. Ann N Y Acad Sci (1998) 1.03
Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex. Neuropharmacology (1984) 1.03
Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT-2 binding site. J Neurosci (1986) 1.03
Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors. J Pharmacol Exp Ther (1987) 1.02
Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists. Mol Pharmacol (1994) 1.01
Serotonin-stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex but not in subcortical regions. J Pharmacol Exp Ther (1985) 1.00
Metabotropic glutamate receptor 5-induced phosphorylation of extracellular signal-regulated kinase in astrocytes depends on transactivation of the epidermal growth factor receptor. J Neurosci (2001) 0.99
Dissecting G protein-coupled receptor signaling pathways with membrane-permeable blocking peptides. Endogenous 5-HT(2C) receptors in choroid plexus epithelial cells. J Biol Chem (2000) 0.98
Increased serotonin turnover in the acutely morphine treated rat. Life Sci I (1971) 0.97
Clozapine blocks disruptive and discriminative stimulus effects of quipazine. Eur J Pharmacol (1984) 0.94
Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms. J Pharmacol Exp Ther (1975) 0.94
Stereoselective LSD-like activity in a series of d-lysergic acid amides of (R)- and (S)-2-aminoalkanes. J Med Chem (1995) 0.92
Sodium-dependent antiporters in choroid plexus epithelial cultures from rabbit. J Neurochem (1993) 0.92
Serotonergic antagonist effects on trafficking of serotonin 5-HT2A receptors in vitro and in vivo. Ann N Y Acad Sci (1998) 0.91
Serotonin receptor sensitivity after acute and chronic treatment with mianserin. J Pharmacol Exp Ther (1982) 0.91
Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor. Psychopharmacology (Berl) (1999) 0.89
Distribution of serotonin 5-HT(2A) receptors in afferents of the rat striatum. Synapse (2001) 0.88
On the mechanism of brain 5-hydroxytryptamine depletion by p-chloroamphetamine and related drugs and the specificity of their action. Adv Biochem Psychopharmacol (1974) 0.88
Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sites. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.87
Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD). Neuropsychopharmacology (1999) 0.87
Serotonin agonists increase transferrin levels via activation of 5-HT1C receptors in choroid plexus epithelium. J Neurosci (1992) 0.86
Biogenic amines and narcotic effects. II. Serotonin turnover in the rat after acute and chronic morphine administration. J Pharmacol Exp Ther (1973) 0.86
Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives. J Med Chem (1997) 0.86
RNA editing of the human serotonin 5-HT(2C) receptor delays agonist-stimulated calcium release. Mol Pharmacol (2000) 0.86
Hallucinogens and Drosophila: linking serotonin receptor activation to behavior. Neuroscience (2002) 0.86
Effect of drugs on amines in the CNS. Annu Rev Pharmacol (1971) 0.85
5-Hydroxytryptamine2C receptors on spinal neurons controlling penile erection in the rat. Neuroscience (1999) 0.85
Generation of anti-peptide antibodies against serotonin 5-HT2A and 5-HT2C receptors. J Neurosci Methods (1997) 0.84
Central serotonin receptors: effector systems, physiological roles and regulation. Psychopharmacology (Berl) (1987) 0.84
Agonist-induced phosphoinositide hydrolysis in choroid plexus. J Neurochem (1986) 0.84
Long-term effects of p-chloroamphetamine on tryptophan hydroxylase activity and on the levels of 5-hydroxytryptamine and 5-hydroxyindole acetic acid in brain. Eur J Pharmacol (1972) 0.84
Differences in agonist-independent and -dependent 5-hydroxytryptamine2C receptor-mediated cell division. Mol Pharmacol (1996) 0.84
Biochemical characterization of serotonin stimulated phosphoinositide turnover. Life Sci (1986) 0.83
The serotonin autoreceptor: antagonism by quipazine. Neuropharmacology (1982) 0.83
Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors. Neuroscience (2002) 0.82
5-Hydroxytryptamine type 2A and 2C receptors linked to Na+/K+/Cl- cotransport. Mol Pharmacol (1994) 0.82
Effector systems coupled to serotonin receptors in brain: serotonin stimulated phosphoinositide hydrolysis. Psychopharmacol Bull (1986) 0.82
Identification of rat serotonin 5-HT2C receptors as glycoproteins containing N-linked oligosaccharides. Brain Res Mol Brain Res (1995) 0.82
Pharmacological properties of the Cys23Ser single nucleotide polymorphism in human 5-HT2C receptor isoforms. Pharmacogenomics J (2005) 0.82
P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin. J Pharmacol Exp Ther (1970) 0.82
Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor. J Pharmacol Exp Ther (1995) 0.81
5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Mol Pharmacol (1993) 0.81
(+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist. J Pharmacol Exp Ther (1991) 0.81
Regulation of serotonin2A receptors in heterologous expression systems. J Neurochem (1994) 0.81
The serotonin/norepinephrine-link in brain. II. Role of serotonin in the regulation of beta adrenoceptors in the low agonist affinity conformation. J Pharmacol Exp Ther (1988) 0.80
Deletion of the serotonin 5-HT2C receptor PDZ recognition motif prevents receptor phosphorylation and delays resensitization of receptor responses. J Biol Chem (2000) 0.80
Quantitative trait loci mapping and gene network analysis implicate protocadherin-15 as a determinant of brain serotonin transporter expression. Genes Brain Behav (2014) 0.80
p-Chloroamphetamine. Temporal relationship between psychomotor stimulation and metabolism of brain norepinephrine. Biochem Pharmacol (1970) 0.80
Phosphoinositide hydrolysis linked 5-HT2 receptors in fibroblasts from choroid plexus. Brain Res (1991) 0.80
Evaluation of heritable determinants of blood and brain serotonin homeostasis using recombinant inbred mice. Genes Brain Behav (2013) 0.80
Long-term effects of fenfluramine on central serotonergic mechanisms. Neuropharmacology (1979) 0.79
Long-term effects of continuous exposure to amphetamine on brain dopamine concentration and synaptosomal uptake in mice. Eur J Pharmacol (1980) 0.79
Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide. Mol Pharmacol (1992) 0.78
Temporal effects of p-chloroamphetamine on catecholamine synthesis. Eur J Pharmacol (1977) 0.78
p-Chloroamphetamine--inhibition of cerebral tryptophan hydroxylase. Biochem Pharmacol (1972) 0.78
Multiple serotonin receptors: regional distribution and effect of Raphe lesions. Eur J Pharmacol (1981) 0.78
Hallucinogens and serotonergic mechanisms. NIDA Res Monogr (1992) 0.78
Behavioral effects of (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus-maze test. Life Sci (1995) 0.78
Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites. J Pharmacol Exp Ther (1984) 0.78
m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine are partial agonists at cloned 5-HT2A receptors expressed in fibroblasts. J Pharmacol Exp Ther (1994) 0.78
Species differences in the rate of disappearance of fenfluramine and its effects on brain serotonin neurons. Biochem Pharmacol (1979) 0.77
Dissecting intracellular signaling pathways with membrane-permeable peptides. Sci STKE (2000) 0.77
Adaptive changes in the 5-HT2 binding site after chronic administration of agonists and antagonists. Neuropharmacology (1986) 0.77
Dissociation between behavioral effects and changes in metabolism of cerebral serotonin following 9 -tetrahydrocannabinol. Psychopharmacologia (1972) 0.77
Adaptation of brain 5HT2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behavior. J Pharmacol Exp Ther (1990) 0.77
Denervation supersensitivity of 5-HT-1c receptors in rat choroid plexus. Brain Res (1987) 0.77
Metabolism of bufotenine-2'-14C in human volunteers. Life Sci (1976) 0.76
The serotonin/noradrenaline-link in brain. I. The role of noradrenaline and serotonin in the regulation of density and function of beta adrenoceptors and its alteration by desipramine. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.76
Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization. Mol Pharmacol (1995) 0.76
p-Chloramphetamine--species differences in the rate of disappearance and the lowering of cerebral serotonin. Biochem Pharmacol (1971) 0.76
Evaluation of the neurotoxic effects of p-chloroamphetamine: a histological and biochemical study. Neuropharmacology (1978) 0.76
Tryptophan hydroxylase activity in developing rat brain. J Neurochem (1971) 0.76
Differences in agonist-independent activity of 5-Ht2A and 5-HT2c receptors revealed by heterologous expression. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.76
Developmental switch in the hippocampal serotonin receptor linked to phosphoinositide hydrolysis. Brain Res (1995) 0.76
Reversible and irreversible effects of p-chloroamphetamine on brain serotonin in mice. Commun Psychopharmacol (1977) 0.76
Rapid tolerance to the motor effects of p-chloroamphetamine in rats. Psychopharmacology (Berl) (1977) 0.75
The serotonin/norepinephrine-linked beta-adrenoceptor system and the mode of action of antidepressants. Psychopharmacol Bull (1985) 0.75
Facilitation of Sidman avoidance performance by p-chloroamphetamine: role of biogenic amines. Neuropharmacology (1977) 0.75
Diazomethane: improved analytical and distillation techniques for small quantities and some synthetic applications. Anal Biochem (1980) 0.75
Tolerance to p-chloroamphetamines effects on Sidman avoidance performance and catecholamine metabolism. Neuropharmacology (1977) 0.75
From neurotransmitter to gene: identifying the missing links. Trends Pharmacol Sci (1991) 0.75
The serotonin-norepinephrine link hypothesis of affective disorders: receptor-receptor interactions in brain. Adv Exp Med Biol (1987) 0.75